Journal article
Thromboxane Antagonism with terutroban in Peripheral Arterial Disease: the TAIPAD study
Abstract
BACKGROUND: Terutroban is a selective prostaglandin endoperoxide (TP) receptor antagonist with antithrombotic, antivasoconstrictive and antiatherosclerotic properties and is currently in development for long-term cardiovascular secondary prevention.
OBJECTIVES: TAIPAD is an international, double-blind, randomized controlled study comparing the effects of five dosages of oral terutroban vs. aspirin and placebo on platelet aggregation in …
Authors
FIESSINGER JN; BOUNAMEAUX H; CAIROLS MA; CLEMENT DL; COCCHERI S; FLETCHER JP; HOFFMANN U; TURPIE AGG; INVESTIGATORS OBOTT
Journal
Journal of Thrombosis and Haemostasis, Vol. 8, No. 11, pp. 2369–2376
Publisher
Elsevier
Publication Date
11 2010
DOI
10.1111/j.1538-7836.2010.04020.x
ISSN
1538-7933